Haematologica

OCT 8, 2026 · JOURNAL ARTICLE

Dual inhibition of JAK and MEK suppresses T-cell acute lymphoblastic leukemia induced by mutant IL7R and RASGRP1 overexpression

Haematologica

Gain-of-function mutant IL-7Rα (mutIL7R) occurs in approximately 10% of patients with Tcell acute lymphoblastic leukemia (T-ALL), an aggressive pediatric cancer. Nearly half of pat

SEP 17, 2026 · JOURNAL ARTICLE

T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?

Haematologica

Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of relapsed or refractory B-cell malignancies and multiple myeloma, with tens of thousands of patien

AUG 13, 2026 · JOURNAL ARTICLE

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap

Haematologica

A White Paper outlining strategic recommendations and a roadmap for international registry collaboration in lymphoma, not reporting original research findings or clinical trial data.